Applied BioCode Corporation (6598.TW)

TWD 20.35

(-0.97%)

Inventory Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual inventory in 2023 was 174.97 Million TWD , up 64.02% from previous year.
Applied BioCode Corporation's latest quarterly inventory in 2024 Q2 was 194.39 Million TWD , down -4.69% from previous quarter.
Applied BioCode Corporation reported annual inventory of 106.67 Million TWD in 2022, up 5.23% from previous year.
Applied BioCode Corporation reported annual inventory of 101.37 Million TWD in 2021, down -4.75% from previous year.
Applied BioCode Corporation reported quarterly inventory of 203.96 Million TWD for 2024 Q1, up 16.57% from previous quarter.
Applied BioCode Corporation reported quarterly inventory of 174.97 Million TWD for 2023 Q4, down -3.46% from previous quarter.

Annual Inventory Chart of Applied BioCode Corporation (2023 - 2012)

Historical Annual Inventory of Applied BioCode Corporation (2023 - 2012)

Year	Inventory	Inventory Growth
2023	174.97 Million TWD	64.02%
2022	106.67 Million TWD	5.23%
2021	101.37 Million TWD	-4.75%
2020	106.43 Million TWD	28.9%
2019	82.57 Million TWD	36.59%
2018	60.45 Million TWD	239.82%
2017	17.78 Million TWD	19.94%
2016	14.83 Million TWD	147.7%
2015	5.98 Million TWD	-18.05%
2014	7.3 Million TWD	17.51%
2013	6.21 Million TWD	-48.09%
2012	11.97 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	194.39 Million TWD	-4.69%
2024 Q1	203.96 Million TWD	16.57%
2023 Q4	174.97 Million TWD	-3.46%
2023 FY	174.97 Million TWD	64.02%
2023 Q2	150.97 Million TWD	14.57%
2023 Q3	181.24 Million TWD	20.05%
2023 Q1	131.77 Million TWD	23.52%
2022 Q1	102.79 Million TWD	1.4%
2022 Q2	122.45 Million TWD	19.13%
2022 Q4	106.67 Million TWD	-11.22%
2022 Q3	120.16 Million TWD	-1.87%
2022 FY	106.67 Million TWD	5.23%
2021 FY	101.37 Million TWD	-4.75%
2021 Q3	103.56 Million TWD	-5.06%
2021 Q4	101.37 Million TWD	-2.12%
2021 Q1	127.23 Million TWD	19.54%
2021 Q2	109.09 Million TWD	-14.26%
2020 Q1	65.98 Million TWD	-20.08%
2020 Q2	92.37 Million TWD	40.0%
2020 Q3	114.88 Million TWD	24.37%
2020 Q4	106.43 Million TWD	-7.36%
2020 FY	106.43 Million TWD	28.9%
2019 Q1	- TWD	-100.0%
2019 FY	82.57 Million TWD	36.59%
2019 Q3	82.33 Million TWD	14.76%
2019 Q2	71.74 Million TWD	0.0%
2019 Q4	82.57 Million TWD	0.29%
2018 Q2	46.29 Million TWD	0.0%
2018 FY	60.45 Million TWD	239.82%
2018 Q4	60.45 Million TWD	0.0%
2018 Q1	46.29 Million TWD	160.23%
2017 FY	17.78 Million TWD	19.94%
2017 Q2	17.83 Million TWD	0.0%
2017 Q1	17.83 Million TWD	20.23%
2017 Q3	17.78 Million TWD	-0.24%
2017 Q4	17.78 Million TWD	0.0%
2016 Q2	9.13 Million TWD	0.0%
2016 Q4	14.83 Million TWD	0.0%
2016 FY	14.83 Million TWD	147.7%
2015 FY	5.98 Million TWD	-18.05%
2015 Q4	5.98 Million TWD	0.0%
2014 FY	7.3 Million TWD	17.51%
2013 FY	6.21 Million TWD	-48.09%
2012 FY	11.97 Million TWD	0.0%

Peer Inventory Comparison of Applied BioCode Corporation

Name	Inventory	Inventory Difference
Excelsior Medical Co., Ltd.	1.24 Billion TWD	85.973%
Apex Medical Corp.	420.28 Million TWD	58.368%
OK Biotech Co., Ltd.	394.04 Million TWD	55.596%